Immunosensitivity Tumors

Tumor immunosensitivity is a condition in which immune cells attack tumor cells and cause their destruction. This can occur in both humans and animals.

The mechanism of tumor immunosensitivity includes several factors. Firstly, this is the reaction of the immune system to antigens that are present on the surface of tumor cells. These antigens can be recognized by T cells, which are then activated and begin to produce cytokines such as interferon-gamma (IFN-γ). IFN-γ stimulates the production of antibodies, which can also attack tumor cells.

Second, tumor immunosensitivity may be caused by the presence of tumor antigens in surrounding tissues. These antigens can stimulate the activation of T cells, which then begin to produce cytokines and antibodies.

Finally, tumor immunosensitivity can also be caused by the presence of tumor proteins that can activate immune cells and cause their activation.

Overall, tumor immunosensitivity is an important mechanism of the body's defense against cancer and may help reduce tumor size and improve patient survival. However, if the immune system begins to attack healthy tissue, it can cause serious side effects and even death for the patient.

Tumor immunodependence is a phenotypic sign of the response of the antitumor immune system, promoting the infiltration of inflammatory cells by antigens, the destruction of tumor cells and organ damage, as well as a reduction in tumor size and an increase in the overall prognosis. Immune-related tumors, mostly neoplasia of the B-cell lymphoma type, are thought to be